Why Did Synopsys (SNPS) Move Today?

Synopsys (SNPS) has drawn fresh attention after agreeing on November 4 to supply its chip design software to startups and medium-sized enterprises through the European Chips Design Platform, extending its reach across Europe’s semiconductor ecosystem.

Recent trading has been choppy for Synopsys, with the share price down 11.67% over the past 30 days but still up 9.42% across the last 90 days. The 1-year total shareholder return of 14.50% points to longer term momentum building despite shorter term weakness.

Scan beyond Synopsys and see which other chip and AI design players are already on investors’ radar with our handpicked 53 AI infrastructure stocks.

For Synopsys, a 30 day slide alongside a solid 1 year return and a fresh push into Europe sets up a familiar tension. Do you accept today’s price, or wait and hope for a cleaner entry later?

Most Popular Narrative: 23% Undervalued

On the most followed narrative, Synopsys screens as undervalued with a fair value of $583.99 against a last close of $450.46, which puts the stock at a meaningful gap to that framework while the business leans into AI heavy chip design and simulation.

The acquisition and integration of Ansys positions Synopsys as the global leader in engineering solutions from silicon to systems, and new data showing Q3 FY26 Ansys revenue of about US$711 million and an expected FY26 contribution of about US$2.98 billion supports the view that this expanded portfolio can continue to influence top line growth and operating earnings as cross sell opportunities scale.

See why 170 investors see Synopsys as 23% undervalued.

Result: Fair Value of $583.99 (UNDERVALUED)

Still, the Synopsys story can change quickly if Ansys integration drags on, or if exposure to China and key customers like Intel becomes a renewed pressure point.

Find out about the key risks to this Synopsys narrative.

Another View: Synopsys Looks Expensive On Earnings

The SWS DCF model paints Synopsys as undervalued against a fair value of $583.99. The earnings multiple tells a different story. Synopsys trades on a P/E of 80.2x, compared with 30.7x for the US Software sector and a fair ratio of 47.1x, which points to a rich entry point rather than a clear bargain. Which lens do you trust more when real money is on the line?

Rather than relying on one tool, you can stress test your own view against a deeper breakdown of Synopsys using our valuation work and then decide how much earnings multiple risk you are comfortable taking at today’s price. See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Mixed signals on Synopsys so far, or a clear setup hiding in plain sight. Act while the data is fresh and test the thesis yourself, starting with the 2 key rewards and 2 important warning signs.

Looking for more investment ideas beyond Synopsys?

If Synopsys has sharpened your thinking, do not stop here. Broader context from other stocks can help you size risk, spot patterns, and refine conviction.

Use the Simply Wall St Screener to pressure test your next moves across different styles, income profiles, and risk levels while market conditions are still in your favor.

• Hunt for mispriced opportunities that pair quality with attractive entry points using our curated 38 high quality undervalued stocks.
• Build a more durable portfolio by focusing on businesses that aim to combine resilience with strong finances through the list of solid balance sheet and fundamentals (25 results).
• Target potential future standouts before the crowd by scanning a focused 19 high quality undiscovered gems.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com